Smart Money · Holder IQ
84 / 100
Above median holder quality (percentile 99 this quarter). Tracked high-scoring holders are adding shares.
ARTV
Artiva Biotherapeutics, Inc. Common StockNASDAQ
$3.96-2.70%
Close Nov 12, 2026
Reading stored signals…
Healthcare • Biotechnology
Factor tilt: Micro-Cap Value
People-network credibilityUncalibrated
No reporting owner has a RED or GREEN connection distinguishable from zero in this publication.
Show all 22 reporting owners
- Fred AslanChief Executive Officer · Director — as filedRED 0 · GREEN 0 · Net 0
- Daniel G. BakerDirector — as filedRED 0 · GREEN 0 · Net 0
- Subhashis BanerjeeChief Medical Officer — as filedRED 0 · GREEN 0 · Net 0
- Jennifer BushCOO, CLO, Compliance Officer — as filedRED 0 · GREEN 0 · Net 0
- Brian DanielsDirector — as filedRED 0 · GREEN 0 · Net 0
- Christopher HoranChief Tech Operations Officer — as filedRED 0 · GREEN 0 · Net 0
- Elizabeth L. HougenDirector — as filedRED 0 · GREEN 0 · Net 0
- Thad Allen HustonChief Financial Officer — as filedRED 0 · GREEN 0 · Net 0
- Peter KolchinskyDirector · 10% reporting owner — as filedRED 0.000001 · GREEN 0 · Net -0.000001
- Neha KrishnamohanChief Financial Officer — as filedRED 0 · GREEN 0 · Net 0
- Gines Diego MirallesPresident & Head of R&D — as filedRED 0 · GREEN 0 · Net 0
- Alison MooreDirector — as filedRED 0 · GREEN 0.000003 · Net 0.000003
- RA Capital Healthcare Fund LPDirector · 10% reporting owner — as filedRED 0 · GREEN 0 · Net 0
- RA CAPITAL MANAGEMENT, L.P.Director · 10% reporting owner — as filedRED 0 · GREEN 0 · Net 0
- RA Capital Nexus Fund III, L.P.Director — as filedRED 0 · GREEN 0 · Net 0
- RA Capital Nexus Fund, L.P.Director — as filedRED 0 · GREEN 0 · Net 0
- Heather RaymonSVP, Research and Development — as filedRED 0 · GREEN 0 · Net 0
- Rajeev M. ShahDirector · 10% reporting owner — as filedRED 0.000001 · GREEN 0 · Net -0.000001
- Elaine K. SorgDirector — as filedRED 0 · GREEN 0 · Net 0
- Laura StoppelDirector — as filedRED 0 · GREEN 0 · Net 0
- GC Cell Corp10% reporting owner — as filedRED 0 · GREEN 0 · Net 0
- GC Corp.10% reporting owner — as filedRED 0 · GREEN 0 · Net 0
How this is measured
A connection is distinguishable from zero here only when its RED or GREEN published interval has a lower bound above zero. A person with an admitted finding is always listed first, even with a zero score. Connections are then ordered by the larger of RED and GREEN. A zero tied with other owners is not given a percentile.
RED measures graph connections to people with admitted adjudications; GREEN measures connections to repeat value creators and stewards of qualifying compounders and long-term shareholder-return leaders. Net is GREEN minus RED on a −1 to 1 scale, not a probability or expected return. Connections alone do not establish conduct. These measures are separate from insider trading performance and Company Quality Grade.
The publication is uncalibrated. Its intervals are published bands, not a claim of calibrated confidence or a tested forecast.
Admitted findings are published guilty pleas, convictions and litigated SEC judgments or orders. Settlements and open cases are not findings. A positive net does not erase an admitted finding. Absence of a finding is not a clearance or a complete regulatory-history search.
Reporting owners who filed from after Oct 9, 2025 through Oct 9, 2026: a 12-month window ending at the publication date. This can include former officers and directors; it is not a verified roster of today's employees.
Link an account to see your stake, watchlist and past holdings. use the cited filings to check the reported role and evidence alongside your investment thesis. A connection alone does not tell you to increase or reduce a holding.
Medians across all 22 scored reporting owners at this company as of Oct 9, 2026: RED 0, GREEN 0, net 0. Highest RED: 0.000001; highest GREEN: 0.000003.
- Issuer CIK
- 0001817241
- Publication as of
- Oct 9, 2026; known by Oct 9, 2026
- Retrieved
- Nov 13, 2026; a new publication can take up to six hours to appear here
- RED source refresh state
- fresh within 8d
- Method
- epg.signed_credibility.raw-uncalibrated.v1
- Population identity
- sha256:733e7e30f755f296f1d478ccb2c8674cb0adf04ebbe89319e08bc8255dddb9c5
- Graph identity
- c6521b138848011b775d9a6dfb7ac59989b2082fdc729ef4f41456a4e2037f60
- Source
- SEC Forms 3, 4 and 5 for roles; the Midas Edge API's active immutable people-network publication for credibility and admitted findings. GREEN seed evidence can include vendor price histories. No portfolio or account data is sent to this product.
Fred Aslan · SEC CIK 0001909362
Read the Form 4 filed Oct 7, 2026Published intervals: RED 0 to 0.02; GREEN 0 to 0.02; net -0.04 to 0.04.
Score identity: 7e80a4e51b9f3b0af33418020ec115a7067fcd1e891bad06253554ca03fbffac
Calibration versions: RED affine-identity-unfitted.v1; GREEN affine-identity-unfitted.v1
Daniel G. Baker · SEC CIK 0002046802
Read the Form 4 filed Sep 14, 2026Published intervals: RED 0 to 0.02; GREEN 0 to 0.02; net -0.04 to 0.04.
Score identity: 7990f7d6f3d299b6e494ff297fc893eb04fa94f4486ab3bfb8032f0d1d84a12b
Calibration versions: RED affine-identity-unfitted.v1; GREEN affine-identity-unfitted.v1
Subhashis Banerjee · SEC CIK 0002065633
Read the Form 4 filed Oct 6, 2026Published intervals: RED 0 to 0.02; GREEN 0 to 0.02; net -0.04 to 0.04.
Score identity: e088d0b537bca746fba10c69c1d5f862714f2c90db3c1f45be714b7d2a402929
Calibration versions: RED affine-identity-unfitted.v1; GREEN affine-identity-unfitted.v1
Jennifer Bush · SEC CIK 0001621152
Read the Form 4 filed Oct 6, 2026Published intervals: RED 0 to 0.02; GREEN 0 to 0.02; net -0.04 to 0.04.
Score identity: bebc30810650c3aa6e3cdb52c5229db6492a10ab8e971f44eeb8ef930a33796e
Calibration versions: RED affine-identity-unfitted.v1; GREEN affine-identity-unfitted.v1
Brian Daniels · SEC CIK 0001428698
Read the Form 4 filed Sep 14, 2026Published intervals: RED 0 to 0.02; GREEN 0 to 0.02; net -0.04 to 0.04.
Score identity: 5a52d6f3604af616da00cebdc34295ede0eca2d0844222f6a2583704373315f7
Calibration versions: RED affine-identity-unfitted.v1; GREEN affine-identity-unfitted.v1
Christopher Horan · SEC CIK 0001736819
Read the Form 4 filed Oct 6, 2026Published intervals: RED 0 to 0.02; GREEN 0 to 0.02; net -0.04 to 0.04.
Score identity: 433edec85e5a4bba7011129bd274c5e5e58da225b77f4c0448aebaec8faac7c1
Calibration versions: RED affine-identity-unfitted.v1; GREEN affine-identity-unfitted.v1
Elizabeth L. Hougen · SEC CIK 0001074773
Read the Form 4 filed Sep 14, 2026Published intervals: RED 0 to 0.02; GREEN 0 to 0.02; net -0.04 to 0.04.
Score identity: 5da9db9dc73738ba1c28f26496572428978d1ae3ec7a02b57563f5fc12eeb295
Calibration versions: RED affine-identity-unfitted.v1; GREEN affine-identity-unfitted.v1
Thad Allen Huston · SEC CIK 0001706052
Read the Form 4 filed Mar 10, 2026Published intervals: RED 0 to 0.02; GREEN 0 to 0.02; net -0.04 to 0.04.
Score identity: bda6329c253464a7f44a6d6b82e88c4d7c8f7bfe50cbbcd2c1c63543bbdaff18
Calibration versions: RED affine-identity-unfitted.v1; GREEN affine-identity-unfitted.v1
Peter Kolchinsky · SEC CIK 0001384859
Read the Form 4 filed Sep 14, 2026Published intervals: RED 0 to 0.020001; GREEN 0 to 0.02; net -0.040001 to 0.039999.
Score identity: a063ed2b9f00b406e7cd9700de8e423bf6ccd0ecf461a2803034b3db09e4cdbf
Calibration versions: RED affine-identity-unfitted.v1; GREEN affine-identity-unfitted.v1
Neha Krishnamohan · SEC CIK 0001866171
Read the Form 4 filed Nov 17, 2025Published intervals: RED 0 to 0.02; GREEN 0 to 0.02; net -0.04 to 0.04.
Score identity: d27b12390e16bf2c04d76cd1fcb2368520b6519b7fde9ef3acce308457c77805
Calibration versions: RED affine-identity-unfitted.v1; GREEN affine-identity-unfitted.v1
Gines Diego Miralles · SEC CIK 0001773413
Read the Form 4 filed Sep 11, 2026Published intervals: RED 0 to 0.02; GREEN 0 to 0.02; net -0.04 to 0.04.
Score identity: a63286cd3f14b14f6b7761cb4ecbb7ecc8abc8764d8c3e165f201d127a911a24
Calibration versions: RED affine-identity-unfitted.v1; GREEN affine-identity-unfitted.v1
Alison Moore · SEC CIK 0001754937
Read the Form 4 filed Sep 14, 2026Published intervals: RED 0 to 0.02; GREEN 0 to 0.020003; net -0.039997 to 0.040003.
Score identity: 4191d510e0ff0296e9306728dc5f59e383aca4381b3586a66f1b0fb007d69f8e
Calibration versions: RED affine-identity-unfitted.v1; GREEN affine-identity-unfitted.v1
RA Capital Healthcare Fund LP · SEC CIK 0001315082
Read the Form 4 filed Sep 14, 2026Published intervals: RED 0 to 0.02; GREEN 0 to 0.02; net -0.04 to 0.04.
Score identity: a9956a76ee6a0b2dbbc410618ff693954338ee11e60e4501bc2b50f961e516c1
Calibration versions: RED affine-identity-unfitted.v1; GREEN affine-identity-unfitted.v1
RA CAPITAL MANAGEMENT, L.P. · SEC CIK 0001346824
Read the Form 4 filed Sep 14, 2026Published intervals: RED 0 to 0.02; GREEN 0 to 0.02; net -0.04 to 0.04.
Score identity: 130b483153b58b0b1054c5c826b4340816ea233ef4e6e588dbb987ede1d926b0
Calibration versions: RED affine-identity-unfitted.v1; GREEN affine-identity-unfitted.v1
RA Capital Nexus Fund III, L.P. · SEC CIK 0001883840
Read the Form 4 filed Sep 14, 2026Published intervals: RED 0 to 0.02; GREEN 0 to 0.02; net -0.04 to 0.04.
Score identity: 5dd7e4726ee15530aa92e6d2f4c0c56dbbf62aaa8f56e56dfbf8b3ac0f1e3ca7
Calibration versions: RED affine-identity-unfitted.v1; GREEN affine-identity-unfitted.v1
RA Capital Nexus Fund, L.P. · SEC CIK 0001780117
Read the Form 4 filed Sep 14, 2026Published intervals: RED 0 to 0.02; GREEN 0 to 0.02; net -0.04 to 0.04.
Score identity: 8fea000c5b421a49fbac94923eb59ca7d45cef679fd1146048e0bd13ca244b5a
Calibration versions: RED affine-identity-unfitted.v1; GREEN affine-identity-unfitted.v1
Heather Raymon · SEC CIK 0002028466
Read the Form 4 filed May 19, 2026Published intervals: RED 0 to 0.02; GREEN 0 to 0.02; net -0.04 to 0.04.
Score identity: bf38d37cfa64e340ccf79704235a7f3d205d1a117895a006a125393e818d9757
Calibration versions: RED affine-identity-unfitted.v1; GREEN affine-identity-unfitted.v1
Rajeev M. Shah · SEC CIK 0001619841
Read the Form 4 filed Sep 14, 2026Published intervals: RED 0 to 0.020001; GREEN 0 to 0.02; net -0.040001 to 0.039999.
Score identity: 24f11d8ec7b2efab153347d84d1446c1f623080c2f5b80de66a79f9921034069
Calibration versions: RED affine-identity-unfitted.v1; GREEN affine-identity-unfitted.v1
Elaine K. Sorg · SEC CIK 0001832571
Read the Form 4 filed Sep 14, 2026Published intervals: RED 0 to 0.02; GREEN 0 to 0.02; net -0.04 to 0.04.
Score identity: 8092b635288fe6159bf7079994a5099702415b19bcceba33fbf2db270f79c920
Calibration versions: RED affine-identity-unfitted.v1; GREEN affine-identity-unfitted.v1
Laura Stoppel · SEC CIK 0001865119
Read the Form 4 filed Sep 14, 2026Published intervals: RED 0 to 0.02; GREEN 0 to 0.02; net -0.04 to 0.04.
Score identity: 200628e164269ec7202267bb7a562961a38c842065bbb66b70437f064da4aa04
Calibration versions: RED affine-identity-unfitted.v1; GREEN affine-identity-unfitted.v1
GC Cell Corp · SEC CIK 0001931891
Read the Form 4 filed May 28, 2026Published intervals: RED 0 to 0.02; GREEN 0 to 0.02; net -0.04 to 0.04.
Score identity: 8dbf12cb8767d23e8defa820fb544465590137beee8c8510afd55f6d1f69aa9d
Calibration versions: RED affine-identity-unfitted.v1; GREEN affine-identity-unfitted.v1
GC Corp. · SEC CIK 0001931382
Read the Form 4 filed May 28, 2026Published intervals: RED 0 to 0.02; GREEN 0 to 0.02; net -0.04 to 0.04.
Score identity: 57130c7e3b98e6ebcb27c3cf14dcb30d716739a3d9664bf71a772f3a3f6cf4f6
Calibration versions: RED affine-identity-unfitted.v1; GREEN affine-identity-unfitted.v1
Read the insider context evidence
What it means for you
Sign in to read your holdings or watchlist context. No personal position or direction is inferred.
What happened
Stored recent-activity label: bearish. This context label is separate from the scored insider signal read.
Why it can matter
A count of reported activity describes a sample, not purchase conviction, an insider’s intent or a future price move. Neutral is not an all-clear, and absent direction is not neutral evidence.
How we got this
The current context rule reads at most 50 nonduplicate issuer/share-class records filed in the last 90 days. It counts a bullish direction or purchase code P toward bullish, and a bearish direction or sale code S toward bearish. A side must exceed the opposite count by more than two to set its label; otherwise nonzero directional counts produce neutral. Calculation unavailable for this saved label: its counts, exact records, as-of time and rule version are not supplied here. Do not substitute the separate scored read’s different window or denominator.
Where the data comes from
Stored SEC Forms 3/4/5 insider-signal records, ordered by filing date with amendment duplicates excluded. Filing date is not transaction date. The last-trade line locates recent reported activity; it does not date or reconstruct the complete count.
- Market cap
- $156.08M
- 1 month
- -33.0%
- 3 months
- -65.4%
- 1 year
- +10.3%
- 52-week range
- $3.07$13.39
More market facts
- Dividend
- No dividends on record
- Latest-quarter EPS estimate
- -$0.53Quarter ended Sep 30, 2026 · 5 analysts · 0.0% in 30d
- Short interest
- 15.1% of float3M shares · settled Oct 30, 2026 · +7.9% since Oct 15, 2026 · FINRA
Estimate history · same fiscal quarter
Quarter ended Sep 30, 2026. Source: Stored analyst estimates.
| Observed / analysts | EPS | Revenue |
|---|---|---|
| 5 analysts | -0.534 | — |
| 5 analysts | -0.534 | — |
| 5 analysts | -0.534 | — |
| 5 analysts | -0.534 | — |
| 5 analysts | -0.534 | — |
Dates identify stored observations, not earnings announcements. Gaps do not mean estimates were unchanged. The analyst group and vendor earnings basis may change.
Link an account to see your stake, watchlist and past holdings. Compare changes in earnings expectations with your investment case. These are analyst estimates, not reported results or a prediction of your return.
Fundamentals · trailing 12 months to Jun 30, 2026
- Revenue
- —
- Net income
- -$90.82M
- Free cash flow
- -$98.1M
- Book value
- $347.5M
- Total debt
- $9.85M
- P/E
- —
- Price / sales
- —
- Price / book
- —
- FCF yield
- —
- Net margin
- —
Trailing twelve-month statements · as of Nov 12, 2026
End-of-day close from stored market data, not a live quote.
About Artiva Biotherapeutics, Inc. Common Stock
Artiva Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing natural killer (NK) cell-based therapies for patients suffering from autoimmune diseases and cancers.
Read more
Its lead product candidate includes AlloNK, an off-the-shelf NK cell therapy for patients with autoimmune diseases and cancers, such as rheumatoid arthritis, systemic lupus erythematosus, lupus nephritis, rheumatoid arthritis, pemphigus vulgaris, the anti-neutrophil cytoplasmic antibody -associated vasculitis subtypes granulomatosis with polyangiitis/microscopic polyangiitis, and B-cell-non-Hodgkin lymphoma. The company also develops AB-201, an allogeneic anti- human epidermal growth factor receptor 2 targeting chimeric antigen receptor (CAR)-NK cell product candidate for the treatment of various solid tumors, such as breast, gastric and esophageal, and bladder cancers; and AB-205, an allogeneic anti-CD5 CAR-NK cell product candidate for the treatment of hematological malignancies. Artiva Biotherapeutics, Inc. was incorporated in 2019 and is headquartered in San Diego, California.
- Website
- artivabio.com
- Headquarters
- San Diego, CA, United States
- Employees
- 115
- Listed
- Jul 19, 2024
- Fiscal year ends
- December
Company profile stored Oct 25, 2026.
Quarterly results
The last 8 fiscal quarters from the latest stored normalized financial statements. These may include restatements. Year over year compares the same quarter a year earlier.
| Quarter | Revenue | YoY | Gross margin | Op. income | Net income |
|---|---|---|---|---|---|
| Jun 2026filed Aug 6, 2026 | — | — | — | -$26.9M | -$25.0M |
| Mar 2026filed May 8, 2026 | — | — | — | -$24.4M | -$23.5M |
| Dec 2025filed Mar 10, 2026 | — | — | — | -$21.9M | -$20.8M |
| Sep 2025filed Nov 12, 2025 | — | — | — | -$22.9M | -$21.5M |
| Jun 2025filed Aug 6, 2025 | — | — | — | -$22.8M | -$21.3M |
| Mar 2025filed May 8, 2025 | — | — | — | -$22.2M | -$20.3M |
| Dec 2024filed Mar 24, 2025 | — | — | — | -$18.3M | -$9.2M |
| Sep 2024filed Nov 12, 2024 | — | — | — | -$18.3M | -$17.5M |
Balance sheet · cash, debt and near-term obligations
What resources sit beside the obligations? These are balances at each fiscal quarter end, not cash earned during the quarter. Amounts are in USD, the reporting currency.
As of
- Reported cash
- $301.5M
- Reported total debt
- $9.8M
- Current assets
- $352.3M
- Current liabilities
- $14.6M
Vendor filing date:
As of
- Reported cash
- $21.0M
- Reported total debt
- $10.3M
- Current assets
- $88.7M
- Current liabilities
- $10.9M
Vendor filing date:
As of
- Reported cash
- $26.7M
- Reported total debt
- $10.9M
- Current assets
- $112.7M
- Current liabilities
- $13.1M
Vendor filing date:
As of
- Reported cash
- $25.5M
- Reported total debt
- $11.7M
- Current assets
- $129.5M
- Current liabilities
- $11.1M
Vendor filing date:
Link an account to see your stake, watchlist and past holdings. Compare cash and debt across dates when reviewing its reliance on financing. Current assets can include receivables and inventory; current liabilities include bills as well as borrowings. They are not all spendable cash or all debt. These figures alone do not establish the ability to repay.
Source: the latest stored normalized balance sheets, matched to the same security and fiscal end as these income periods. They may include restatements and are not an originally-filed or knowledge-time history. No net debt, coverage ratio or replacement balance is calculated. Read the SEC guide to financial statements for the distinction between balances and cash flows.
Fiscal years · last 6
| Fiscal year | Revenue | YoY | Gross margin | Op. income | Net income |
|---|---|---|---|---|---|
| Dec 2025filed Mar 10, 2026 | — | — | — | -$90.6M | -$83.9M |
| Dec 2024filed Mar 24, 2025 | $251.0K | -99.3% | 100.0% | -$67.3M | -$58.5M |
| Dec 2023filed Dec 31, 2023 | $33.5M | +579.2% | 100.0% | -$30.7M | -$27.7M |
| Dec 2022filed Dec 31, 2022 | $4.9M | +146.3% | 100.0% | -$59.8M | -$58.4M |
| Dec 2021filed Dec 31, 2021 | $2.0M | — | 100.0% | -$53.3M | -$71.8M |
| Dec 2020filed Dec 31, 2020 | — | — | — | -$18.3M | -$18.0M |
Annual cash generation
Does profit turn into cash? Compare ARTV’s accounting profit with operating cash flow and capital spending. Amounts are in USD.
Fiscal year ending
- Net income
- -$83.9M
- Operating cash flow
- -$76.8M
- Capital spending
- $2.6M
- Free cash flow
- -$79.3M
Fiscal year ending
- Net income
- -$58.5M
- Operating cash flow
- -$55.0M
- Capital spending
- $642.0K
- Free cash flow
- -$55.7M
Fiscal year ending
- Net income
- -$27.7M
- Operating cash flow
- -$47.4M
- Capital spending
- $3.3M
- Free cash flow
- -$50.7M
Earlier cash-flow years
Fiscal year ending
- Net income
- -$58.4M
- Operating cash flow
- -$50.8M
- Capital spending
- $6.3M
- Free cash flow
- -$57.1M
Fiscal year ending
- Net income
- -$71.8M
- Operating cash flow
- -$15.3M
- Capital spending
- $1.7M
- Free cash flow
- -$17.0M
Fiscal year ending
- Net income
- -$18.0M
- Operating cash flow
- -$13.5M
- Capital spending
- $284.0K
- Free cash flow
- -$13.8M
Link an account to see your stake, watchlist and past holdings. Compare cash generation and investment needs with your thesis. Working capital and non-cash charges can separate profit from cash. Capital spending can reduce free cash flow while earnings rise. For a long or short position, that gap alone does not predict a price move.
Cash-flow source and meaning
Source: Annual financial statements, latest stored vendor-normalized figures. These may include restatements and may differ from the filer’s own XBRL. A filing date is not the knowledge date of this version of the values.
Free cash flow is the vendor’s reported figure, shown only when it agrees with operating cash flow less capital spending recorded as a positive outflow. It is not cash guaranteed for dividends or buybacks, and it does not subtract every financing obligation. Missing or sign-incompatible inputs are not filled in. An unlabelled currency is used only for a confirmed domestic USD filer. These are annual statements, not forecasts or an originally-filed history.
Cash allocation: dividends, shares and debt
Where did ARTV’s financing cash go? Compare cash paid as dividends with net share and debt transactions across fiscal years. Amounts are in USD, the reporting currency. These are company-wide totals, not per-share payouts.
Fiscal year ended
Vendor filing date:
- Net share issuance / purchases
- $0.0
- Net borrowing / repayment
- -$132.0K
- Total financing cash flow
- $9.0K
Fiscal year ended
Vendor filing date:
- Net share issuance / purchases
- -$4.2M
- Net borrowing / repayment
- -$149.0K
- Total financing cash flow
- $162.2M
Fiscal year ended
Vendor filing date:
- Net share issuance / purchases
- -$12.0K
- Net borrowing / repayment
- $0.0
- Total financing cash flow
- $24.4M
Fiscal year ended
Vendor filing date:
- Net share issuance / purchases
- -$5.0K
- Total financing cash flow
- -$1.3M
Fiscal year ended
Vendor filing date:
- Net borrowing / repayment
- $0.0
- Total financing cash flow
- $152.8M
Fiscal year ended
Vendor filing date:
- Total financing cash flow
- $37.4M
Link an account to see your stake, watchlist and past holdings. Compare these uses of cash with operating cash generation and the debt on the balance sheet. A negative net share movement means purchases exceeded issuance; it does not give gross buybacks. A dividend or share purchase can be financed with borrowing, and none of these flows guarantees a future payment or price return.
Allocation source and sign conventions
Source: Annual cash-flow statements, latest stored vendor-normalized values for the same security and fiscal year. These can include restatements; a filing date is not the knowledge date of this version.
Dividends are positive cash paid out. For net share transactions, net borrowing and total financing, positive means cash in and negative means cash out. Net share transactions combine issuance and purchases; they are not gross repurchases, a change in shares outstanding, or stock compensation. Total financing includes other flows and is not the sum of just these three lines. Zero means a reported zero. No FX conversion, shareholder-return total or forecast is inferred.
Short-interest history
Reported short positions, stored float percentages and adjusted prices over the same period.
Shares short
Share of float
Adjusted close · USD
Settlement records · 55 observations
Settlement Oct 30, 2026
2,953,973 shares short
+215,932 shares (+7.9%) vs Oct 15, 2026
15.1% of the stored float. Published Nov 10, 2026.
Settlement Oct 15, 2026
2,738,041 shares short
+441,307 shares (+19.2%) vs Sep 30, 2026
14.1% of the stored float. Published Oct 26, 2026.
Settlement Sep 30, 2026
2,296,734 shares short
+231,584 shares (+11.2%) vs Sep 15, 2026
11.8% of the stored float. Published Oct 9, 2026.
Settlement Sep 15, 2026
2,065,150 shares short
+229,013 shares (+12.5%) vs Aug 31, 2026
20.4% of the stored float. Published Sep 24, 2026.
Settlement Aug 31, 2026
1,836,137 shares short
-259,676 shares (-12.4%) vs Aug 14, 2026
18.2% of the stored float. Published Sep 10, 2026.
Settlement Aug 14, 2026
2,095,813 shares short
+173,970 shares (+9.1%) vs Jul 31, 2026
Published Aug 25, 2026.
Settlement Jul 31, 2026
1,921,843 shares short
+197,769 shares (+11.5%) vs Jul 15, 2026
Published Aug 11, 2026.
Settlement Jul 15, 2026
1,724,074 shares short
+384,147 shares (+28.7%) vs Jun 30, 2026
Published Jul 24, 2026.
Settlement Jun 30, 2026
1,339,927 shares short
+260,408 shares (+24.1%) vs Jun 15, 2026
Published Jul 10, 2026.
Settlement Jun 15, 2026
1,079,519 shares short
+54,106 shares (+5.3%) vs May 29, 2026
Published Jun 25, 2026.
Settlement May 29, 2026
1,025,413 shares short
+544,834 shares (+113.4%) vs May 15, 2026
Published Jun 9, 2026.
Settlement May 15, 2026
480,579 shares short
+250,762 shares (+109.1%) vs Apr 30, 2026
Published May 27, 2026.
Settlement Apr 30, 2026
229,817 shares short
+81,330 shares (+54.8%) vs Apr 15, 2026
Published May 11, 2026.
Settlement Apr 15, 2026
148,487 shares short
+288 shares (+0.2%) vs Mar 31, 2026
Published Apr 24, 2026.
Settlement Mar 31, 2026
148,199 shares short
+1,066 shares (+0.7%) vs Mar 13, 2026
Published Apr 10, 2026.
Settlement Mar 13, 2026
147,133 shares short
-1,702 shares (-1.1%) vs Feb 27, 2026
Published Mar 24, 2026.
Settlement Feb 27, 2026
148,835 shares short
-40,286 shares (-21.3%) vs Feb 13, 2026
Published Mar 10, 2026.
Settlement Feb 13, 2026
189,121 shares short
-14,671 shares (-7.2%) vs Jan 30, 2026
Published Feb 25, 2026.
Settlement Jan 30, 2026
203,792 shares short
-81,152 shares (-28.5%) vs Jan 15, 2026
Published Feb 10, 2026.
Settlement Jan 15, 2026
284,944 shares short
-106,156 shares (-27.1%) vs Dec 31, 2025
Published Jan 27, 2026.
Settlement Dec 31, 2025
391,100 shares short
+212,912 shares (+119.5%) vs Dec 15, 2025
Published Jan 12, 2026.
Settlement Dec 15, 2025
178,188 shares short
+17,755 shares (+11.1%) vs Nov 28, 2025
Published Dec 24, 2025.
Settlement Nov 28, 2025
160,433 shares short
-60,846 shares (-27.5%) vs Nov 14, 2025
Published Dec 9, 2025.
Settlement Nov 14, 2025
221,279 shares short
-35,698 shares (-13.9%) vs Oct 31, 2025
Published Nov 25, 2025.
Settlement Oct 31, 2025
256,977 shares short
+53,187 shares (+26.1%) vs Oct 15, 2025
Published Nov 11, 2025.
Settlement Oct 15, 2025
203,790 shares short
-23,944 shares (-10.5%) vs Sep 30, 2025
Published Oct 24, 2025.
Settlement Sep 30, 2025
227,734 shares short
-63,200 shares (-21.7%) vs Sep 15, 2025
Published Oct 9, 2025.
Settlement Sep 15, 2025
290,934 shares short
-14,076 shares (-4.6%) vs Aug 29, 2025
Published Sep 24, 2025.
Settlement Aug 29, 2025
305,010 shares short
+534 shares (+0.2%) vs Aug 15, 2025
Published Sep 10, 2025.
Settlement Aug 15, 2025
304,476 shares short
-1,718 shares (-0.6%) vs Jul 31, 2025
Published Aug 26, 2025.
Settlement Jul 31, 2025
306,194 shares short
-190,895 shares (-38.4%) vs Jul 15, 2025
Published Aug 11, 2025.
Settlement Jul 15, 2025
497,089 shares short
-152,929 shares (-23.5%) vs Jun 30, 2025
Published Jul 24, 2025.
Settlement Jun 30, 2025
650,018 shares short
-585,864 shares (-47.4%) vs Jun 13, 2025
Published Jul 10, 2025.
Settlement Jun 13, 2025
1,235,882 shares short
-39,580 shares (-3.1%) vs May 30, 2025
Published Jun 25, 2025.
Settlement May 30, 2025
1,275,462 shares short
-119,985 shares (-8.6%) vs May 15, 2025
Published Jun 10, 2025.
Settlement May 15, 2025
1,395,447 shares short
-62,509 shares (-4.3%) vs Apr 30, 2025
Published May 27, 2025.
Settlement Apr 30, 2025
1,457,956 shares short
+22,433 shares (+1.6%) vs Apr 15, 2025
Published May 9, 2025.
Settlement Apr 15, 2025
1,435,523 shares short
+354,338 shares (+32.8%) vs Mar 31, 2025
Published Apr 25, 2025.
Settlement Mar 31, 2025
1,081,185 shares short
+227,085 shares (+26.6%) vs Mar 14, 2025
Published Apr 9, 2025.
Settlement Mar 14, 2025
854,100 shares short
-270,253 shares (-24%) vs Feb 28, 2025
Published Mar 25, 2025.
Settlement Feb 28, 2025
1,124,353 shares short
-58,767 shares (-5%) vs Feb 14, 2025
Published Mar 11, 2025.
Settlement Feb 14, 2025
1,183,120 shares short
+15,417 shares (+1.3%) vs Jan 31, 2025
Published Feb 26, 2025.
Settlement Jan 31, 2025
1,167,703 shares short
-83,287 shares (-6.7%) vs Jan 15, 2025
Published Feb 11, 2025.
Settlement Jan 15, 2025
1,250,990 shares short
+82,182 shares (+7%) vs Dec 31, 2024
Published Jan 27, 2025.
Settlement Dec 31, 2024
1,168,808 shares short
+145,134 shares (+14.2%) vs Dec 13, 2024
Published Jan 10, 2025.
Settlement Dec 13, 2024
1,023,674 shares short
-7,609 shares (-0.7%) vs Nov 29, 2024
Published Dec 24, 2024.
Settlement Nov 29, 2024
1,031,283 shares short
+95,510 shares (+10.2%) vs Nov 15, 2024
Published Dec 10, 2024.
Settlement Nov 15, 2024
935,773 shares short
+27,242 shares (+3%) vs Oct 31, 2024
Published Nov 26, 2024.
Settlement Oct 31, 2024
908,531 shares short
-31,993 shares (-3.4%) vs Oct 15, 2024
Published Nov 11, 2024.
Settlement Oct 15, 2024
940,524 shares short
+99,658 shares (+11.9%) vs Sep 30, 2024
Published Oct 24, 2024.
Settlement Sep 30, 2024
840,866 shares short
+774,456 shares (+1,166.2%) vs Sep 13, 2024
Published Oct 9, 2024.
Settlement Sep 13, 2024
66,410 shares short
+15,085 shares (+29.4%) vs Aug 30, 2024
Published Sep 24, 2024.
Settlement Aug 30, 2024
51,325 shares short
-5,404 shares (-9.5%) vs Aug 15, 2024
Published Sep 11, 2024.
Settlement Aug 15, 2024
56,729 shares short
+28,554 shares (+101.3%) vs Jul 31, 2024
Published Aug 26, 2024.
Settlement Jul 31, 2024
28,175 shares short
Published Aug 9, 2024.
Change = this settlement’s shares short − the previous recorded settlement’s shares short; percentage change divides by that earlier count. A zero earlier count has no percentage change. Split-spanning counts are left uncompared. Float percentages use the stored settlement observation, not today’s float.
Source: stored FINRA equity short-interest records. Adjusted prices exclude a reused ticker’s earlier issuer. FINRA data and reporting dates · How to read short interest
Portfolio context
Link an account to see your stake, watchlist and past holdings.
We’ll show you if ARTV is in your portfolio and how much it contributes.
Sign inMarket context
Smart money context
Holder IQ: HIGH
24 smart-money holders: institutions with a high Holder IQ
Q2 2026, filed Sep 22, 2026
Smart-money 13F trend: accumulating (heavy)
Unlock crowding heatmapUnlock filer discoveryInsider context
Sentiment: bearish
Last trade: sell 10 days ago
Read the insider context evidence
What it means for you
Sign in to read your holdings or watchlist context. No personal position or direction is inferred.
What happened
Stored recent-activity label: bearish. This context label is separate from the scored insider signal read.
Why it can matter
A count of reported activity describes a sample, not purchase conviction, an insider’s intent or a future price move. Neutral is not an all-clear, and absent direction is not neutral evidence.
How we got this
The current context rule reads at most 50 nonduplicate issuer/share-class records filed in the last 90 days. It counts a bullish direction or purchase code P toward bullish, and a bearish direction or sale code S toward bearish. A side must exceed the opposite count by more than two to set its label; otherwise nonzero directional counts produce neutral. Calculation unavailable for this saved label: its counts, exact records, as-of time and rule version are not supplied here. Do not substitute the separate scored read’s different window or denominator.
Where the data comes from
Stored SEC Forms 3/4/5 insider-signal records, ordered by filing date with amendment duplicates excluded. Filing date is not transaction date. The last-trade line locates recent reported activity; it does not date or reconstruct the complete count.
Red flags: 8
Largest 13-F holders · Q2 2026
72 filers reported a long position in ARTV for Q2 2026. 13-F holdings are filed up to 45 days after the quarter ends.
The top 10 hold
84%
of the 40.4M shares 13-F filers reported
Moves vs Q1 2026
4 added0 trimmed
5 new · 1 unchanged
Net shares held
+74.2%
across the 5 holders with a comparable Q1 2026 book
| Rank | Holder | Value | Shares | Shares vs Q1 2026 |
|---|---|---|---|---|
| 1 | Ra Capital Management, L.P. | $174.2M · 18M shares | 18M | +82.2% |
| 2 | Viking Global Investors LP | $25.3M · 2.6M shares | 2.6M | New |
| 3 | Blackstone Inc. | $23.3M · 2.4M shares | 2.4M | New |
| 4 | 5AM Venture Management, LLC | $22.8M · 2.4M shares | 2.4M | Unchanged |
| 5 | Venrock Adviser, LLC | $19.8M · 2M shares | 2M | +27% |
| 6 | Franklin Resources Inc | $19.4M · 2M shares | 2M | +283.8% |
| 7 | Caligan Partners LP | $16.8M · 1.7M shares | 1.7M | New |
| 8 | Vanguard Capital Management LLC | $9.5M · 981.8K shares | 981.8K | +372.7% |
| 9 | Samsara BioCapital, LLC | $9.3M · 954.9K shares | 954.9K | New |
| 10 | Blue Owl Capital Holdings LP | $8.5M · 874.5K shares | 874.5K | New |
Sign in to see each holder’s Holder IQ, factor-adjusted Holder IQ and rank, and compare these holders with all scored filers. Available on every plan.
Sign in5% holder filings (13D / 13G)
Holders of more than 5% of ARTV file with the SEC within days. A 13D holder may seek to influence the company; a 13G holder is passive. Each holder’s latest filing from the last three years.
| Filed | Holder | % of class |
|---|---|---|
| Aug 14, 2026 | Venrock Healthcare Capital Partners III LP13G · passive · amended | 4.2%under 5% |
| Aug 10, 2026 | 5AM Ventures VI LP13G · passive · amended | 4.8%under 5% |
| Jul 23, 2026 | Ra Capital Management, L.P.13D · activist · amended | 37.9% |
| May 28, 2026 | GC Corp13D · activist · amended | 12.3% |
| May 18, 2026 | Viking Global Investors LP13G · passive | 5.4% |
Moves the factor model did not explain
How much of ARTV’s move accompanied the market and its measured style leanings, and how much was left? The residual is unexplained by this fitted model. It does not establish a cause, skill or future alpha.
- Market
- -0.52%
- Style leanings
- -10.72%
- Unexplained residual
- -23.41%
- Stock move
- -34.65%
Window contributions are percentage points of starting stock value. The market bar is the fitted common intercept, not an index return. Market + styles + residual = stock move; opposite signs can offset. Source: daily_returns, dated security_factor_exposures × barra_factor_returns, and stored security_specific_returns; 2026-10-15–2026-11-12, model v1.2.0. Returns are dimensionless on the USD listing; no currency conversion.
Link an account with dated transactions to see what share of your own holding’s move since its purchase-date close was unexplained, with long and short positions distinguished. Your private holdings never enter this public chart.
Dated model observations (20)
Daily percentage returns, not window contributions. Source: the same dated warehouse rows and model v1.2.0; observed 2026-11-13T15:53:49.222Z. Absent sessions are never interpolated; missing or failed inputs stay unavailable.
| Date | Stock | Market | Styles | Residual |
|---|---|---|---|---|
| -3.47% | -1.05% | -8.27% | +5.85% | |
| +0.68% | +0.36% | +3.89% | -3.56% | |
| +11.38% | +0.43% | +0.93% | +10.01% | |
| -1.07% | +0.49% | +1.53% | -3.08% | |
| -4.47% | -1.09% | -8.59% | +5.21% | |
| -0.81% | -0.46% | +2.44% | -2.79% | |
| +0.16% | +0.50% | +2.21% | -2.55% | |
| -30.68% | +0.68% | +7.96% | -39.32% | |
| +0.12% | +0.37% | +2.85% | -3.10% | |
| -1.05% | -0.46% | -1.30% | +0.70% | |
| -0.95% | -1.77% | -11.80% | +12.63% | |
| 0.00% | -0.24% | -5.73% | +5.97% | |
| +0.24% | +0.35% | +3.50% | -3.60% | |
| +0.48% | +1.75% | -8.59% | +7.31% | |
| -2.13% | -3.95% | -11.72% | +13.54% | |
| +0.48% | +0.71% | +7.70% | -7.93% | |
| +1.69% | +2.42% | +6.70% | -7.43% | |
| -3.79% | -0.29% | +0.28% | -3.78% | |
| +0.25% | +1.19% | +5.06% | -6.01% | |
| -2.70% | -0.45% | -4.49% | +2.24% |
How this split is calculated
Each day uses that day’s fitted market intercept and style exposures multiplied by that day’s published factor returns. Their sum plus the independently stored residual must reconcile to the stock return. Window effects are weighted by stock wealth at each day’s start and added; the stock return compounds. Every expected US market session must be present and pass source, identity, model and numerical checks. This retrospective fit is an explanation of measured returns, not evidence of causation or an investable forecast. The window ends at the latest published model session, which can lag the market; today’s unfinished session is excluded.
What insiders reported owning
Reading dated filing evidence…
Get the Full Analysis for ARTV
Unlock detailed insider transactions, institutional holder changes, factor exposures, and personalized alerts. Start free with your own portfolio.